Anthem Biosciences Ltd. (ANTHEM): Anthem Biosciences Share Price rises 3.31% to Rs 903.90; market cap at Rs 49,768.65 crore
- August 26, 2026
- Posted by: Harsh Piplani
- Category: News
Anthem Biosciences Share Price moved higher today as the stock rose 3.31% to Rs 903.90 from Rs 874.90, adding Rs 29.00 in the session. The company’s market capitalisation stood at Rs 49,768.65 crore, keeping Anthem Biosciences Ltd. in the spotlight in the Indian stock market. The price event is relevant because it shows a clear same-day share price gain, even though the supplied data does not establish a company-specific catalyst.
Anthem Biosciences Stock News is therefore being tracked mainly through verified market data: the stock opened at Rs 876.00, touched a low of Rs 876.00 and a high of Rs 904.95, and ended close to the day’s upper end. Turnover for the session was Rs 1.91 crore. For readers following Anthem Biosciences Share Price Today, Univest is presenting the move as a factual price rise with valuation and sector context rather than as a catalyst-led event.
The stock is listed on NSE and BSE, and the current move keeps Anthem Biosciences Share Price on the radar for those watching Stocks in News, Market News and share price rise updates. Univest notes that the supplied data confirms the price event, while the reason for the move is not specified in the dataset.
Anthem Biosciences Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 903.9 |
| Previous Close | Rs 874.9 |
| Today's Move | Rs 29 (+3.31%) |
| Open | Rs 876 |
| High | Rs 904.95 |
| Low | Rs 876 |
| Turnover | Rs 1.91 crore |
| Market Capitalisation | Rs 49,768.65 crore |
| Market Cap Category | Large Cap |
Anthem Biosciences Ltd. (ANTHEM) rose to Rs 903.9 from the previous close of Rs 874.9, a move of Rs 29 or 3.31%. The stock opened at Rs 876, reached a high of Rs 904.95, recorded a low of Rs 876.
Anthem Biosciences Share Price Today shows a steady intraday rise. The stock closed at Rs 903.90 versus the previous close of Rs 874.90, which translates into a gain of Rs 29.00 or 3.31%. The day’s range was narrow, with Rs 876.00 as both the open and the low, and Rs 904.95 as the high. That places the close just below the session peak, which is useful factual context for readers scanning Anthem Biosciences Share Price Live and Anthem Biosciences Share News. Univest is treating this as a verified same-day price rise and not attributing it to any unstated trigger.
The move also places Anthem Biosciences among Stocks Rising Today and Top Gainers Today on a percentage basis, while keeping the narrative grounded in the supplied numbers. Because the article must remain evidence-led, it focuses on the actual price move, the Rs 1.91 crore turnover and the Rs 49,768.65 crore market cap rather than trying to explain the session with unsupported assumptions. For anyone checking Anthem Biosciences Stock Gaining Today or Anthem Biosciences Share Price Update, the headline fact is the 3.31% advance.
Anthem Biosciences Ltd. (ANTHEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 49,768.65 crore |
| P/E Ratio | 85.59x |
| P/B Ratio | 15.75x |
| ROE | 21.98% |
| ROCE | 29.62% |
| EPS | Rs 10.22 |
| Book Value Per Share | Rs 55.55 |
| Dividend Yield | 0.23% |
Anthem Biosciences Ltd. (ANTHEM) fundamental metrics show P/E 85.59x, P/B 15.75x, ROE 21.98%, ROCE 29.62%. These figures provide context only and are not a buy or sell signal.
Anthem Biosciences Ltd. has a market capitalisation of Rs 49768.65 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 85.59x, P/B at 15.75x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 21.98% and ROCE of 29.62%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 10.22, book value per share of Rs 55.55, dividend yield of 0.23%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.52x, median ROE of 11.82%, median ROCE of 13.88%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 85.59x |
| Benchmark Median P/E | 30.52x |
| Benchmark Average P/E | 46.79x |
| Benchmark P/E Range | 2.94x to 717.81x |
| Company P/B Ratio | 15.75x |
| Benchmark Median P/B | 2.71x |
| Company ROE | 21.98% |
| Benchmark Median ROE | 11.82% |
| Company ROCE | 29.62% |
| Benchmark Median ROCE | 13.88% |
| Company Market Capitalisation | Rs 49,768.65 crore |
| Benchmark Median Market Cap | Rs 613.53 crore |
Anthem Biosciences Ltd. (ANTHEM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Anthem Biosciences Ltd. (ANTHEM) has a P/E ratio of 85.59x, which is above the benchmark median of 30.52x, a difference of +180.44%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Anthem Biosciences Ltd. (ANTHEM) has a ROE of 21.98%, which is above the benchmark median of 11.82%, a difference of +85.96%. Anthem Biosciences Ltd. (ANTHEM) has a ROCE of 29.62%, which is above the benchmark median of 13.88%, a difference of +113.4%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,58,248.99 | 38.03 | 5.32 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,25,648.29 | 78.78 | 13.05 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,84,891.11 | 85.81 | 20.85 | 26.76 | 19.27 |
| Cipla Ltd. | CIPLA | 1,15,926.93 | 34.03 | 3.26 | 11.83 | 16 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,09,825.17 | 24.98 | 4.18 | 19.69 | 21.39 |
Anthem Biosciences Ltd. (ANTHEM) has a P/E ratio of 85.59x compared with the displayed peer median of 38.03x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 21.98% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 29.62% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Anthem Biosciences Ltd. (ANTHEM) has a market capitalisation of Rs 49,768.65 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Anthem Biosciences
- The Anthem Biosciences Share Price rose 3.31% today to Rs 903.90 after closing at Rs 874.90 previously.
- The session high was Rs 904.95, while the open and low were both Rs 876.00.
- Market capitalisation stood at Rs 49,768.65 crore, which is far above the industry median of Rs 613.53 crore.
- P/E is 85.59, P/B is 15.75, ROE is 21.98% and ROCE is 29.62%.
- Peer numbers place Anthem Biosciences close to the top end on P/E and above all listed peers on ROCE.
About Anthem Biosciences
Anthem Biosciences Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data does not provide a product-level business breakdown, so the company overview here stays limited to the verified sector and industry classification. For readers following Anthem Biosciences Stock Performance, that classification is still useful because it places the company within a competitive pharmaceutical peer set where valuation and profitability comparisons are meaningful.
What stands out from the available figures is the scale of the business and the financial ratios already discussed. The market cap of Rs 49,768.65 crore places Anthem Biosciences well above the industry median, while the supplied EPS of Rs 10.22, book value of Rs 55.55 and dividend yield of 0.23% provide a compact financial snapshot. Univest will continue to map Anthem Biosciences Share Price against the broader sector and peer universe as new public data becomes available.
Track Anthem Biosciences Share Price on Univest
Use Anthem Biosciences Ltd. (ANTHEM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Readers can track Anthem Biosciences Share Price on Univest for live price updates, fundamental ratios, shareholding pattern, 52-week levels and market insights in one place. Univest also brings together Anthem Biosciences Stock News, comparative valuation, sector context and company-specific data so that users can monitor the stock with a cleaner view of the facts.
For investors searching Anthem Biosciences Share Price Today, Anthem Biosciences Share Price Live or Anthem Biosciences Latest News, Univest keeps the coverage focused on verified metrics and simple comparisons. That makes it easier to follow the stock without mixing the current share price rise with unsupported assumptions or predictions.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Anthem Biosciences Share Price rising today?
Ans. The supplied data confirms a 3.31% same-day rise in Anthem Biosciences Share Price to Rs 903.90, but it does not establish a company-specific catalyst. Univest is therefore treating it as a verified price rise.
What is Anthem Biosciences Share Price today?
Ans. Anthem Biosciences Share Price today is Rs 903.90, compared with the previous close of Rs 874.90. The stock added Rs 29.00 during the session and finished near the day’s high of Rs 904.95.
What is the market capitalisation of Anthem Biosciences?
Ans. Anthem Biosciences has a market capitalisation of Rs 49,768.65 crore. That is well above the industry median of Rs 613.53 crore and the average of Rs 13,734.53 crore in the supplied benchmark.
How does Anthem Biosciences look on valuation?
Ans. Anthem Biosciences Share Price is backed by a P/E of 85.59 and a P/B of 15.75. Both are above the same-industry medians, so the stock trades at a premium to the benchmark set.
What do Anthem Biosciences ROE and ROCE show?
Ans. Anthem Biosciences reports ROE of 21.98% and ROCE of 29.62%. Both are above the same-industry medians, which gives useful context for Anthem Biosciences Share Price when compared with peer profitability.
How does Anthem Biosciences compare with peers?
Ans. In the supplied peer set, Anthem Biosciences has a higher P/E than most listed peers and the highest ROCE. Its market cap is below Sun Pharmaceutical and Divi’s Laboratories, but above Cipla and Zydus Lifesciences.
What are the key financial numbers for Anthem Biosciences?
Ans. Key figures include EPS of Rs 10.22, book value of Rs 55.55 and dividend yield of 0.23%. These metrics add context to Anthem Biosciences Share Price, especially when read alongside valuation and profitability ratios.
Should investors track Anthem Biosciences Share Price on Univest?
Ans. Yes, Univest lets users track Anthem Biosciences Share Price with live updates, ratios, shareholding pattern, 52-week levels and market insights. That keeps the stock’s price action and fundamentals in one place.
